Cargando…

Circulating Biomarkers in Cardiovascular Disease

Detalles Bibliográficos
Autor principal:	Ingelsson, Erik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2009
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833610/ https://www.ncbi.nlm.nih.gov/pubmed/19773608 http://dx.doi.org/10.3233/DMA-2009-0644

Ejemplares similares

Circulating Retinol-Binding Protein 4 and Subclinical Cardiovascular Disease in the Elderly
por: Ingelsson, Erik, et al.
Publicado: (2009)

Biomarkers of Cardiovascular Disease
por: Huang, Ying, et al.
Publicado: (2017)

Biomarkers and the Fontan Circulation
por: Schumacher, Kurt R., et al.
Publicado: (2016)

Circulating Cancer Biomarkers
por: Lokshin, Anna, et al.
Publicado: (2021)

Emerging New Biomarkers for Cardiovascular Disease
por: Rochette, Luc
Publicado: (2022)

Year of Expanding into Circulating Biomarkers
por: Jia, Shidong, et al.
Publicado: (2015)

Circulating endothelial cells as biomarker for cardiovascular diseases
por: Farinacci, Maura, et al.
Publicado: (2018)

Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Circulating Noncoding RNAs as Candidate Biomarkers of Endocrine and Metabolic Diseases
por: Sebastiani, Guido, et al.
Publicado: (2018)

Roles and Clinical Applications of Biomarkers in Cardiovascular Disease
por: de Franciscis, Stefano, et al.
Publicado: (2016)

Biomarkers in Cardiovascular Disease: The Dilemma of Racial Differences
por: Suzuki, Toru, et al.
Publicado: (2019)

Find the Essence through the Phenomena: Cardiovascular Diseases and Biomarkers
por: Shi, Zhongjie, et al.
Publicado: (2018)

Roles and Clinical Applications of Biomarkers in Cardiovascular Disease 2017
por: Serra, Raffaele, et al.
Publicado: (2017)

The Grand Challenge of Cardiovascular Epidemiology: Turning the Tide
por: Ingelsson, Erik
Publicado: (2014)

Effect of Magnesium Supplementation on Circulating Biomarkers of Cardiovascular Disease
por: Alonso, Alvaro, et al.
Publicado: (2020)

The quest for a biomarker of circulating osteoclast precursors
por: Ritchlin, Christopher
Publicado: (2009)

Olfactomedin 4 as a circulating biomarker for asthma
por: Jang, An-Soo
Publicado: (2022)

Find the Essence through the Phenomena: Cardiovascular Diseases and Biomarkers 2019
por: Wei, Shipeng, et al.
Publicado: (2020)

Utility of Circulating MicroRNAs as Clinical Biomarkers for Cardiovascular Diseases
por: Kondkar, Altaf A., et al.
Publicado: (2015)

Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
por: Felekkis, Kyriacos, et al.
Publicado: (2020)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Circulating mitochondrial DNA as a biomarker for lung cancer screening
por: von Itzstein, Mitchell S., et al.
Publicado: (2022)

Cardiovascular Inflammation 2012: Reactive Oxygen Species, SUMOylation, and Biomarkers in Cardiovascular Inflammation
por: Abe, Jun-Ichi, et al.
Publicado: (2013)

Cardiovascular Biomarkers: Current Status and Future Directions
por: Filipovic, Mark G., et al.
Publicado: (2023)

Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases
por: de Freitas, Renata Caroline Costa, et al.
Publicado: (2021)

Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?
por: Ligi, D, et al.
Publicado: (2016)

Circulating miRNAs as Tumor Biomarkers: A Preface to the Special Issue
por: Markou, Athina N.
Publicado: (2020)

Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies
por: Mandraffino, Giuseppe, et al.
Publicado: (2022)

A brief review of biomarkers for preventing and treating cardiovascular diseases
por: Sun, Xiaolun, et al.
Publicado: (2012)

Inflammatory Cardiovascular Risk Biomarkers: Update on Novelties and Limitations
por: Montecucco, Fabrizio, et al.
Publicado: (2012)

Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis
por: Ielapi, Nicola, et al.
Publicado: (2020)

Development and validation of risk prediction models for multiple cardiovascular diseases and Type 2 diabetes
por: Rezaee, Mehrdad, et al.
Publicado: (2020)

Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases
por: Li, Meng, et al.
Publicado: (2015)

Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review
por: Navickas, Rokas, et al.
Publicado: (2016)

A comparison of echocardiographic and circulating cardiac biomarkers for predicting incident cardiovascular disease
por: Lind, Lars, et al.
Publicado: (2022)

Cardiovascular disease biomarkers derived from circulating cell-free DNA methylation
por: Cuadrat, Rafael R C, et al.
Publicado: (2023)

Circulating biomarkers of cardiovascular disease are related to aneurysm volume in abdominal aortic aneurysm
por: Bouwens, Elke, et al.
Publicado: (2023)

Iatrogenic myocarditis—biomarkers, cardiovascular MRI and the need for early diagnosis
por: Lota, Amrit S, et al.
Publicado: (2018)

Journal of Circulating Biomarkers looks forward after being indexed in PubMed Central
por: Kuo, Winston Patrick
Publicado: (2017)

Vascular Biomarkers: Physics Parameters and Circulating Molecules Can Be Two Faces of the Same Coin
por: Zamboni, Paolo
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fapnc4ga98mcqd4dlj6d03oouo